AbbVie Taiwan

AbbVie Taiwan operates as a research-based biopharmaceutical entity focused on the discovery, development, manufacture, and commercialization of proprietary pharmaceutical products. As a key player in the regional healthcare sector, the organization maintains a robust portfolio of therapeutic solutions designed to address complex medical conditions. The company currently supports a workforce of 500-1,000 employees who drive innovation across its clinical and operational pipelines. Meet AbbVie Taiwan's team to understand the leadership and scientific expertise guiding their regional strategy.

The firm maintains its primary operational footprint in Taipei City, Taiwan, specifically located at Section 3 Minsheng East Road, 104 Fl 15, No 49. This single-location facility serves as the central hub for all administrative, regulatory, and commercial activities within the Taiwanese market. By concentrating resources in this strategic location, AbbVie Taiwan ensures efficient coordination of its pharmaceutical distribution and clinical research initiatives, maintaining high standards of operational excellence in the competitive biopharmaceutical landscape.

With a commitment to advancing patient outcomes, AbbVie Taiwan leverages global research capabilities to deliver specialized healthcare products. The company continues to integrate advanced biopharmaceutical methodologies to meet the evolving needs of the local medical community. By focusing on high-impact therapeutic areas, the organization sustains its market position as a reliable provider of essential medical treatments. Their ongoing efforts in the pharmaceutical industry reflect a dedication to scientific rigor and long-term value creation for stakeholders throughout the region.